XML 21 R7.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Statements of Equity - USD ($)
$ in Thousands
Common Stock
Additional Paid-In-Capital
(Accumulated Deficit) Retained Earnings
Accumulated Other Comprehensive Income
Total Common Equity
Noncontrolling Interests in Subsidiaries
Total
Balance at Oct. 31, 2022 $ 73 $ 30,635 $ (6,208) $ 1,409 $ 25,909 $ (1,170) $ 24,739
Balance (in Shares) at Oct. 31, 2022 7,321            
Stock based compensation expense 11 11 11
Vested share units granted to directors 26 26 26
Vested share units granted to directors (in Shares) 2            
Stock awards granted to directors 140 140 140
Stock awards granted to directors (in Shares) 9            
Stock options exercised $ 1 1,262 1,263 1,263
Stock options exercised (in Shares) 118            
Distributions to noncontrolling interests in subsidiaries (3,535) (3,535)
Net income (loss) 760 760 (1,335) (575)
Dividends declared (3,520) (3,520) (3,520)
Net unrealized loss on interest rate swap contracts (73) (73) (73)
Balance at Oct. 31, 2023 $ 74 32,074 (8,968) 1,336 24,516 (6,040) 18,476
Balance (in Shares) at Oct. 31, 2023 7,450            
Stock based compensation expense 1 1 1
Stock awards granted to directors $ 1 140 141 141
Stock awards granted to directors (in Shares) 8            
Stock options exercised 38 38 38
Stock options exercised (in Shares) 5            
Distributions to noncontrolling interests in subsidiaries (2,220) (2,220)
Net income (loss) 15,852 15,852 1,081 16,933
Dividends declared (6,343) (6,343) (6,343)
Net unrealized loss on interest rate swap contracts (830) (830) (830)
Net unrealized gain (loss) on investment in U.S. treasury securities available-for-sale (12) (12) (12)
Balance at Oct. 31, 2024 $ 75 32,253 541 494 33,363 (7,179) 26,184
Balance (in Shares) at Oct. 31, 2024 7,463            
Stock awards granted to directors 140 140 140
Stock awards granted to directors (in Shares) 8            
Distributions to noncontrolling interests in subsidiaries (794) (794)
Net income (loss) 3,509 3,509 (363) 3,146
Dividends declared (2,690) (2,690) (2,690)
Net unrealized loss on interest rate swap contracts (296) (296) (296)
Net unrealized gain (loss) on investment in U.S. treasury securities available-for-sale 13 13 13
Balance at Oct. 31, 2025 $ 75 $ 32,393 $ 1,360 $ 211 $ 34,039 $ (8,336) $ 25,703
Balance (in Shares) at Oct. 31, 2025 7,471